Longpre Lara 4
4 · Mirum Pharmaceuticals, Inc. · Filed Nov 15, 2023
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Award
Common Stock
2023-11-10$22.29/sh+434$9,673→ 106,273 total
Footnotes (1)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 434 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.